The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute Mania
Open accessThe DOI matches its Crossref record; 257 of the 257 references it cites were found in a registry or an index.
Abstract
These updated guidelines are based on a first edition that was published in 2003, and have been edited and updated with the available scientific evidence until end of 2008. Their purpose is to supply a systematic overview of all scientific evidence pertaining to the treatment of acute mania in adults. The data used for these guidelines have been extracted from a MEDLINE and EMBASE search, from the clinical trial database clinicaltrials.gov, from recent proceedings of key conferences, and from various national and international treatment guidelines. Their scientific rigor was categorised into six levels of evidence (A-F). As these guidelines are intended for clinical use, the scientific evidence was finally asigned different grades of recommendation to ensure practicability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–257 of 257
Plasma concentrations of high‐dose olanzapine in a double‐blind crossover study
Kelly, D. L., Richardson, C. M., Yu, Y., & Conley, R. R. (2006) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.781 · Cited by 48
Vieta, E., Herraiz, M., Parramón, G., Goikolea, J. M., Fernández, A., & Benabarre, A. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00481-5 · Cited by 48
Self-citationVieta, E., Panicali, F., GOETZ, I. A., Reed, C. C., Comes, M., & Tohen, M. F. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.05.009 · Cited by 47
Self-citationAn Open-Label Study of Amisulpride in the Treatment of Mania
Vieta, E., Ros, S., Goikolea, J. M., Benabarre, A., Popova, E., Comes, M., Capapey, J., & Sánchez-Moreno, J. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0505 · Cited by 46
Self-citationThe treatment of mixed states and the risk of switching to depression
Vieta, E. (2005) · European Psychiatry · doi:10.1016/j.eurpsy.2004.12.002 · Cited by 45
Self-citationAngst, J. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0502-5 · Cited by 45
Bowden, C., Göğüş, A., Grunze, H., Häggström, L., Rybakowski, J., & Vieta, E. (2008) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3282fd827c · Cited by 43
Self-citationOlanzapine: A Review of its Use in the Management of Bipolar I Disorder
McCormack, P. L., & Wiseman, L. R. (2004) · Drugs · doi:10.2165/00003495-200464230-00006 · Cited by 42
Jährliche Krankheitskosten bipolarer Störungen in Deutschland
Runge, C., & Grunze, H. (2004) · Der Nervenarzt · doi:10.1007/s00115-004-1691-x · Cited by 41
Self-citationA Preliminary Open-Label Study of Zonisamide Treatment for Bipolar Depression in 10 Patients
Anand, A., Bukhari, L., Jennings, S. A., Lee, C., Kamat, M., Shekhar, A., Nürnberger, J. I., & Lightfoot, J. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0206 · Cited by 39
Antiepileptic Drugs in Mood‐Disordered Patients
Gajwani, P., Forsthoff, A., Muzina, D. J., Amann, B. L., Gao, K., Elhaj, O., Calabrese, J. R., & Grunze, H. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.463008.x · Cited by 38
Self-citationSocial adjustment based on reported behaviour in bipolar affective disorder
Morriss, R. K., Scott, J. L., Paykel, E. S., Bentall, R. P., Hayhurst, H., & Johnson, T. L. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00343.x · Cited by 38
McIntyre, R. S., Mancini, D. A., Parikh, S. V., & Kennedy, S. H. (2001) · The Canadian Journal of Psychiatry · doi:10.1177/070674370104600402 · Cited by 37
Psychiatric Diagnosis and Risk for Tardive Dyskinesia
Hamra, B. J. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790030116019 · Cited by 35
Elphick, M. (1985) · The British Journal of Psychiatry · doi:10.1192/bjp.147.2.198 · Cited by 35
Clonazepam in acute and maintenance treatment of bipolar affective disorder.
Chouinard, G. (1987) · PubMed · Cited by 35
Revised Korean medication algorithm for bipolar disorder
Jon, D., Bahk, W., Yoon, B. H., Shin, Y. C., Cho, H. S., Lee, E. M., Ha, K., Kim, W. K., Chung, S. K., Seo, J. S., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802144865 · Cited by 34
Oxcarbazepine in the treatment of bipolar and schizoaffective disorders
Popova, E., Leighton, C., Bernabarre, A., Bernardo, M., & Vieta, E. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.6.617 · Cited by 34
Self-citationAripiprazole: pharmacology and evidence in bipolar disorder
McIntyre, R. S., Soczynska, J. K., Woldeyohannes, H. O., Miranda, A., & Konarski, J. Z. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.7.1001 · Cited by 31
Ziprasidone for the Treatment of Acute Manic or Mixed Episodes Associated with Bipolar Disorder
Warrington, L. E., Lombardo, I., Loebel, A. D., & Ice, K. S. (2007) · CNS Drugs · doi:10.2165/00023210-200721100-00004 · Cited by 30
Psychological treatment for bipolar disorders
Gutierrez, M. J., & Scott, J. L. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0463-8 · Cited by 30
[Use of valpromide in psychiatric therapeutics].
Lambert, P. A., & Venaud, G. (1988) · PubMed · Cited by 30
Kasper, S. F., Lowry, A. J., Hodge, A. T., Bitter, I., & Dossenbach, M. R. K. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.07.032 · Cited by 29
Self-citationSanford, M., & Scott, L. J. (2008) · CNS Drugs · doi:10.2165/00023210-200822040-00005 · Cited by 29
A pilot study of rapid lithium administration in the treatment of acute mania
Keck, P. E., Strakowski, S. M., Hawkins, J. M., Dunayevich, E., Tugrul, K. C., Bennett, J. A., & McElroy, S. L. (2001) · Bipolar Disorders · doi:10.1034/j.1399-5618.2001.030204.x · Cited by 28
Treatment of manic episodes: Zuclopenthixol and Clonazepam versus Lithiim and Clonazepam
Gouliaev, G., Licht, R. W., Vestergaard, P., Merinder, L. B., Lund, H., & Bjerre, L. (1996) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1996.tb09812.x · Cited by 26
Self-citationComparison of therapeutic modalities for mania.
Small, J. G., Klapper, M. H., Milstein, V., Marhenke, J. D., & Small, I. F. (1996) · PubMed · Cited by 25
Garber, A. J., Johnson, D. L., Krauss, R. M., Marder, S. R., Meagher, J., McIntosh, B., & Newcomer, J. W. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0619 · Cited by 24
[Carbamazepine in manic syndromes. A controlled double-blind study].
Gonçalves, N., & Kd, S. (1985) · PubMed · Cited by 24
Lima, L. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90145-r · Cited by 23
Normal cerebral volume asymmetries in early onset schizophrenia
Hadjulis, M., Pipe, R., & Frangou, S. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01905-4 · Cited by 23
Palit, G., Kumar, R., Chowdhury, S. R., Gupta, M. B., Saxena, R. C., Srimal, R. C., & Dhawan, B. N. (1998) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(97)00071-0 · Cited by 22
Quetiapine dosage in bipolar disorder episodes and mixed states
Khazaal, Y., Tapparel, S., Chatton, A., Rothen, S., Preisig, M., & ZULLINO, D. F. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.01.006 · Cited by 22
Keck, P. E., Bowden, C. L., Meinhold, J. M., Gyulai, L., Prihoda, T. J., Baker, J. D., & Wozniak, P. J. (2005) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651500500305622 · Cited by 22
Self-citationLithium in the acute treatment of bipolar disorders?a stocktaking
Grunze, H. (2003) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-003-0427-4 · Cited by 20
Self-citationRelevance of new and newly rediscovered anticonvulsants for atypical forms of bipolar disorder
Grunze, H., & Walden, J. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00339-7 · Cited by 20
Self-citationClark, H. M., Berk, M., & Brook, S. (1997) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/(sici)1099-1077(199707/08)12:4<325::aid-hup856>3.0.co;2-h · Cited by 20
Valproate treatment and the risk of hyperandrogenism and polycystic ovaries
Soares, J. C. (2000) · Bipolar Disorders · doi:10.1034/j.1399-5618.2000.020105.x · Cited by 19
Olanzapine plasma level in relation to antimanic effect in the acute therapy of manic states
Bech, P., Gex‐Fabry, M., Aubry, J., Favre, S., & Bertschy, G. (2006) · Nordic Journal of Psychiatry · doi:10.1080/08039480600601282 · Cited by 18
Thomas, P., & Vieta, E. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s3135 · Cited by 18
Self-citationPeh, A. L. H., & Tay, L. K. (2008) · PubMed · Cited by 16
Clinical Trials in Bipolar Mania: Implications in Study Design and Drug Development
Tohen, M. F. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.44 · Cited by 15
Zotepine loading in acute and severely manic patients: a pilot study
Amann, B. L., Sterr, A., Mergl, R., Dittmann, S., Seemüller, F., Dobmeier, M., Orth, M., Schaefer, M., & Grunze, H. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00241.x · Cited by 15
Self-citationTreatment of Mixed Mania with Risperidone and Mood Stabilizers
Benabarre, A., Vieta, E., Colom, F., Martinez, A., Reinares, M., & Corbella, B. (2001) · The Canadian Journal of Psychiatry · doi:10.1177/070674370104600925 · Cited by 13
Self-citationBook Review: DSM-IV: Handbook of Diagnosis and Treatment of DSM IV Personality Disorders
Links, P. S. (1997) · The Canadian Journal of Psychiatry · doi:10.1177/070674379704200114 · Cited by 13
Manic patients receiving ECT in a Brazilian sample
Volpe, F. M., & Júnior, A. R. T. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00356-7 · Cited by 11
Letmaier, M., Schreinzer, D., Reinfried, L., Glauninger, G., Thierry, N., Kapitany, T., & Kasper, S. F. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705006073 · Cited by 8
Self-citationOn variability of effects for a metaanalysis of rheumatoid arthritis radiographic progression.
Anderson, J. (2000) · PubMed · Cited by 8
Carbamazepine, Other Anticonvulsants and Augmenting Agents
Grunze, H. (2005) · doi:10.1002/0470017953.ch5 · Cited by 7
Self-citationPrevalence of Bipolar Disorders
Benazzi, F. (2005) · Psychotherapy and Psychosomatics · doi:10.1159/000084006 · Cited by 7
Dose, M., & Emrich, H. M. (1995) · CNS Drugs · doi:10.2165/00023210-199503060-00003 · Cited by 7
Datto, C. J., Nordenhem, A., Minkwitz, M. C., Dettore, B., Acevedo, L. M., Darko, D. F., & Cutler, A. J. (2009) · European Psychiatry · doi:10.1016/s0924-9338(09)70806-5 · Cited by 7
McIntyre, R. S., Panagides, J., Alphs, L. D., Cohen, M., Lancaster, S., & Macek, T. A. (2007) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(07)70567-9 · Cited by 6
Clonazepam Treatment of Atypical Bipolar Disorder
Pande, A. C. (1988) · Psychosomatics · doi:10.1016/s0033-3182(88)72372-5 · Cited by 6
McIntyre, R. S., Hirschfeld, R. M. A., Alphs, L. D., Cohen, M., Macek, T. A., & Panagides, J. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.12.016 · Cited by 4
Electroconvulsive therapy in treatment-resistant mania: case reports
Soares, M. B. D. M., Moreno, R. A., & Moreno, D. H. (2002) · Revista do Hospital das Clínicas · doi:10.1590/s0041-87812002000100006 · Cited by 2
Efficacy of Divalproex vs Lithium and Placebo in the Treatment of Mania
Bowden, C. L. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510360044034 · Cited by 1
Self-citation
Cited by
AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011
Hiemke, C., Baumann, P., Bergemann, N., Conca, A., Dietmaier, O., Egberts, K., Fric, M., Gerlach, M., Greiner, C., Gründer, G., et al. (2011) · Pharmacopsychiatry · doi:10.1055/s-0031-1286287 · Cited by 868
Malhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842
“Furthermore, even between episodes of illness, individuals with mood disorders often continue to suffer subthreshold depressive symptoms, which can compromise their quality of life, limit functioning and increase the risk of relapse (Grunze et al., 2009).”
BackgroundHasan, A., Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., Thibaut, F., Möller, H.-J., & the Wfsbp Task Force on Treatment Guidelines for Schizophrenia (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2012.696143 · Cited by 637
Self-citationBauer, M., Pfennig, A., Severus, E., Whybrow, P. C., Angst, J., Möller, H.-J., & Šon behalf of the Task Force on Unipolar Depressive Disorders (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.804195 · Cited by 632
“According to Bandelow et al. (2008) and Grunze et al. (2009), six categories of evidence (CE A to F) were used: CE A: Full evidence from controlled trials CE B: Limited positive evidence from controlled trials CE C: Evidence from uncontrolled studies or case reports/expert opinion CE D:…”
MethodSelf-citationCipriani, A., Barbui, C., Salanti, G., Rendell, J., Brown, R., Stockton, S., Purgato, M., Spineli, L. M., Goodwin, G. M., & Geddes, J. R. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60873-8 · Cited by 631
Self-citation
Metadata
- Authors
- Grunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Möller, H.-J., Kasper, S., WFSBP Task Force on Treatment Guide, Grunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Möller, H.-J., Kasper, S., & WFSBP Task Force on Treatment Guide
- Venue
- The World Journal of Biological Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2009-01
- Volume
- 10
- Issue
- 2
- Pages
- 85-116
- ISSN
- 1562-2975 (ISSN-L)
- 1814-1412
- OpenAlex
- W2139073163
- Cited by
- 346
- References
- 257
- FWCI
- 19.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.